The overlap analysis between the filtered Ex gene list and the clinical AD drug targets produced three gene matches (TKT, APP, and GABRA1), which mainly plays a role in regulating microglial cell activation, astrocyte activation and neuron maintenance, suggesting important pathway in AD development (Supplementary Table S2H). The gene discussed is APP; the disease is Alzheimer disease.